Pharma wants a knife: cashed-up mayne keen to cut some deals

SYDNEY: Mayne Pharma is now cashed up and ready to pounce on attractive ... read more

Mesoblast hopes $65m raising will end cash flow ‘chatter’

MELBOURNE: Mesoblast chief executive Silviu Itescu says the biotech’s ability to raise $US45m ... read more

Intermediate Capital joins race for Healius day surgery unit

LONDON: Intermediate Capital has surfaced as a bidder for Healius’ day surgery unit, ... read more

Lumos Diagnostics cash crisis looms as value tumbles 95pc

MELBOURNE: Melbourne-based medtech company Lumos Diagnostics is in danger of running out of ... read more